diabetestalk.net

Welchol For Diabetes

Common Side Effects Of Welchol (colesevelam Hcl) Drug Center - Rxlist

Common Side Effects Of Welchol (colesevelam Hcl) Drug Center - Rxlist

Tell your doctor if you have unlikely but serious side effects of Welchol including: The recommended dose of Welchol to treat primary hyperlipidemia or type 2 diabetes mellitus in adults is 6 tablets once daily or 3 tablets twice daily. Take with a meal and liquid. Do not take other medications at the same time unless your doctor has told you to, as Welchol may make it harder for your body to absorb certain other medications. Welchol may interact with phenytoin , blood thinners, glyburide , thyroid hormone replacement, or birth control pills. Tell your doctor all medications you use. During pregnancy, Welchol should be used only if prescribed. This medication is unlikely to pass into breast milk or harm a nursing infant. Consult your doctor before breastfeeding. Our Welchol (colesevelam hydrochloride) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Because clinical studies are conducted under widelyvarying conditions, adverse reaction ratesobserved in the clinical studies of adrug cannot be directly compared to rates in clinical studies of another drugand may not reflect the rates observed in practice. In 7 double-blind, placebo-controlled, clinical trials,807 patients with primary hyperlipidemia (age range 18-86 years, 50% women, 90%Caucasians, 7% Blacks, 2% Hispanics, 1% Asians) and elevated LDL - C were treatedwith WELCHOL 1.5 g/day to 4.5 g/day from 4 to 24 weeks (total exposure 199patient-years). In clinical trials for the reduction of LDL-C, 68% ofpatients receiving WELCHOL vs. 64% of patients re Continue reading >>

Cholesterol Drug Can Now Treat Type 2

Cholesterol Drug Can Now Treat Type 2

People with Type 2 diabetes who use metformin , sulfonylureas (such as glipizide, glyburide, and glimepiride), insulin , or a combination of these drugs can now add colesevelam (brand name Welchol) to their regimens if they need to further improve their diabetes control. On January 18, the U.S. Food and Drug Administration (FDA) approved this new use for Welchol, which was originally approved in 2000 to help people reduce their LDL, or bad, cholesterol levels. In recent clinical trials, the drug has also been shown to help reduce improve blood glucose control in people with Type 2 diabetes. Now doctors can prescribe it as an add-on drug therapy for that purpose. People with diabetes have an increased risk of cardiovascular disease (which can cause heart attack and stroke ). This is why controlling both blood glucose levels and blood lipid levels (cholesterol and triglycerides ) is so important for people who have diabetes. Welchol is now the only drug that is approved to lower LDL cholesterol levels and blood glucose levels. The results of the most recent study of Welchol were presented at the 2007 American Diabetes Associations Scientific Sessions. The studys participants already took metformin, and some also took other blood-glucoselowering drugs. For the study, some were assigned to add Welchol to the drugs they took, and some received a placebo . After 26 weeks, the people who took Welchol plus metformin had an average reduction in their HbA1c levels (a measure of long-term blood glucose control) of 0.47% compared to those who took a placebo plus metformin. When the people who added Welchol to a combination of drugs were included in the analysis, the Welchol group reduced HbA1c levels by 0.54% compared to those who took a placebo. The participants who took Welcholn Continue reading >>

Welcoming Welchol - Diabetes Developments

Welcoming Welchol - Diabetes Developments

A year ago the U.S. Food and Drug Administration approved a new drug to treat type 2 diabetes. But few of us ever heard of it. Until now. Studies presented at the annual convention of the American Association of Clinical Endocrinologists in Houston on Friday finally caught our attention. The senior author of one of those studies spoke at length with me at the convention. Yehuda Handelsman, an endocrinologist in private practice in Tarzana, California, led a 16-week multi-center international study comparing how well Welchol (colesevelam HCl), Avandia, and Januvia did. In the study they randomized 169 people to evaluate the effects of these three oral diabetes medications on glycemic control and lipid profiles when added to metformin. Each of them significantly improved glycemic control and were generally safe and well-tolerated in the study. But only Welchol also significantly reduced LDL (bad) cholesterol. In fact, the LDL levels of people taking both Avandia and Januvia significantly increased. This is important news for those of us with diabetes, because the LDL levels of most of us is too high. Diabetes and high levels of LDL are two key components of the metabolic syndrome . Welchol (pronounced like well-call with a silent h) is in fact the only drug that the FDA has approved both for controlling blood glucose and LDL cholesterol, as Dr. Handlesman emphasized to me when I interviewed him. While only recently did the FDA approve Welchol for controlling type 2 diabetes, it was way back in the year 2000 that the agency approved Welchol to reduce LDL cholesterol. The FDA hasnt approved Welchol to be taken alone for glucose control. And it does work better in combination with other drugs, Dr. Handelsman told me. Dr. Yehuda Handelsman Led the new Diabetes Study of Welch Continue reading >>

Welchol Works In The Digestive Tract And Is Not Broken Down By The Liver

Welchol Works In The Digestive Tract And Is Not Broken Down By The Liver

Welchol, along with diet and exercise, lowers LDL or "bad" cholesterol. It can be taken alone or with other cholesterol-lowering medications known as statins. Welchol lowers LDL cholesterol in boys, and in girls who have had a menstrual period, ages 10 to 17 years, with a condition known as heterozygous familial hypercholesterolemia (a genetic disorder that causes high cholesterol) alone or with other cholesterol-lowering medications known as statins after inadequate control with diet alone. Welchol, along with diet and exercise, also lowers blood sugar levels in adult patients with type 2 diabetes mellitus when added to other anti-diabetes medications (metformin, sulfonylureas, or insulin). Welchol should not be used to treat type 1 diabetes or diabetic ketoacidosis. Welchol has not been studied with all anti-diabetes medications. Welchol has not been studied in children younger than 10 years old or in girls who have not had a menstrual period. Welchol is available by prescription only. Ask your HCP if Welchol is right for you. Welchol is not for everyone, especially those with: a history of intestinal blockage, blood triglyceride levels of greater than 500 mg/dL, or a history of pancreatitis (inflammation of the pancreas) due to high triglyceride levels. Welchol has not been shown to prevent heart disease or heart attacks. Tell your health care provider (HCP) if you have high triglycerides (greater than 300 mg/dL). Tell your HCP if you have stomach or intestinal problems, including gastroparesis (when the stomach takes too long to empty its contents), abnormal contractions of the digestive system, a history of major gastrointestinal tract surgery, if you have trouble swallowing, or if you have vitamin A, D, E, or K deficiencies. Welchol has known interactions with cyc Continue reading >>

Welchol (colesevelam) - Side Effects, Dosage, Interactions - Drugs

Welchol (colesevelam) - Side Effects, Dosage, Interactions - Drugs

Welchol is the brand name of a prescription drug whose active ingredient is colesevelam. Welchol is used to lower levels of the "bad" cholesterol, or low-density lipoprotein (LDL), when combined with proper diet and exercise. Welchol belongs to group of drugs known as antihyperlipidemics. It works by binding to acids in the bile of your intestines that carry cholesterol into your blood stream. Welchol was originally approved by the Food and Drug Administration (FDA) in 2000 and is manufactured by Daiichi Sankyo. Although originally approved by the FDA to treat cholesterol, studies showed that Welchol had long-term effects on lowering blood sugar in people with type 2 diabetes. How exactly Welchol works to lower blood sugar remains unclear. Studies show that Welchol, when taken with metformin (Gluophage), Amaryl ( glimepiride ), Glucotrol or Glucotrol XL ( glipizide ), or Diabeta ( glyburide ), lowered both fasting blood sugar and the three-month lab marker for diabetes known as A1C. It's important to point out that people who have type 1 diabetes or diabetic ketoacidosis should not take Welchol. You are allergic to Welchol or any of the other ingredients found in the drug You have a blockage in your stomach or gut or a history of such problems You have high triglycerides (triglyceride count greater than 500 mg/dl) You have high cholesterol in the blood caused by high triglycerides Talk to your doctor before taking Welchol if: Your triglycerides range from 300 mg/ dl to 500 mg/dl You have problems with food getting stuck and not moving properly through your gut You are at risk of having blockages in your gut You have phenylketonuria (some forms of Welchol contain phenylalanine) You are likely to have low levels of vitamins A, D, E, or K You have had major surgery on you Continue reading >>

Bile Acid Sequestrants (colesevelam, Welchol)

Bile Acid Sequestrants (colesevelam, Welchol)

Bile Acid Sequestrants (Colesevelam, Welchol) Bile acid sequestrants (BAS) are cholesterol-lowering medications that also lower blood sugar levels in people with type 2 diabetes . This class of drug helps to get rid of cholesterol in the body, especially the harmful cholesterol known as LDL cholesterol. It is common for people with diabetes to have elevated LDL cholesterol. These medications were originally developed to treat hypercholesterolemia. They were found by a study mentioned in Diabetes Care to reduce coronary heart disease, death, and nonfatal heart attacks by 19% compared to a placebo in those with hypercholesterolemia. The way these drugs workis by the medicationbinding with bile acids in the digestive system which are then replaced in the body by cholesterol, effectively lowering cholesterol. This is because bile acids are made in the body when cholesterol is broken down. Below is a visual to show the difference between a BAS method ofgetting rid of cholesterol versus a statins method: Colesevelam (Welchol) is the only BAS approved for lowering blood sugar in patients with type 2 diabetes in the US. Colesevelam was studied in a clinical trial which showed that it not only helped lower blood sugar but LDL cholesterol in patients with type 2 diabetes. Colestimide and colestilan are currently approved for use for type 2 diabetes in Japan. Safety and Side Effectsof Bile Acid Sequestrants BAS medications are not absorbed into the bloodstream and work well for patients who might not be able to safely take certain medications due to their liver. Patients may notice common side effects like indigestion,gas,and mild or moderate constipation but studies have shown colesevelamto be well tolerated by patients and to not cause weight gain . In a study checking the safe Continue reading >>

Can Welchol Help Diabetic Patients?

Can Welchol Help Diabetic Patients?

Home /Can Welchol Help Patients with Diabetes? Wouldnt it be nice if your diabetes diagnosis came with a manual? If youre a type 2 diabetic, you may feel like you already have that manual in your mind. Its filled with the names of more drugs than you can count along with a hazy sense of what each one does. Check that mental manuals table of contents, and youll find an entire section dedicated to cholesterol medications. One of them is Welchol. But it turns out this drug also belongs in another category, the category directly related to blood sugar control. If your doctor prescribed Welchol for your diabetes, you may have questions. How does it work? How can it both treat cholesterol and regulate blood sugar? What is it, exactly? Weve got you covered. Consider this your introduction to Welchol, from the drugs origins to side effects and precautions to take before adding it to your regimen. Welchol is a brand name. When the drug does its taxes, metaphorically speaking, it writes colesevelam on the forms. Colesevelam is part of a class of medications called bile acid sequestrants. Bile acid sequestrants have been around since the 1970s, and they work to lower low-density lipoprotein or LDL, the bad cholesterol. Colesevelam lowers cholesterol by sequestering and binding up the bile acids in our bodies, hence the name bile acid sequestrants. Since we need bile acids for digestion, our bodies have to find them from another source. And wouldnt you know it, cholesterol is just such a source. To review, when we take colesevelam, it robs our digestion process of bile acids. To replace the bile acids, our bodies make new ones from cholesterol, so we have less cholesterol in our systems. Cutting out the middle steps, we can say colesevelam lowers cholesterol. But how do we get fro Continue reading >>

Welchol Diabetes Drug Approved By Fda

Welchol Diabetes Drug Approved By Fda

The Japanese drug manufacturer Daiichi Sankyo has received approval for its supplemental new drug application Welchol (colesevelam HCl) for oral suspension from the Food and Drug Administration (FDA) in the United States. Welchol for oral suspension is taken in conjunction with either a diet soft drink or fruit juice, and can be prescribed for adult patients with type 2 diabetes or primary hyperlipidemia . Welchol is also intended to help improve low-density lipoprotein (LDL, or so-called bad cholesterol) and glycaemic control when it is taken in combination with diet and exercise by adult patients with high LDL cholesterol and type 2 diabetes , the only drug approved by the FDA that does this. Oliseyenum Nwose, head of medical research and strategy therapeutic areas hypertension and metabolism at Daiichi Sankyo, commented "Since the approval of once-daily Welchol for Oral Suspension, we've seen that patients appreciate the flexible dosing options provided by Welchol, taken as tablets with a meal and liquid, or as a drinkable formulation with a meal, to help them reach their LDL-C and A1C goals." He added "We are pleased that patients, depending on their preference, can now choose to mix their Welchol for Oral Suspension with fruit juice, diet soft drinks or water. Welchol for Oral Suspension is once-daily, sugar-free , citrus-flavored and non-systemically absorbed, which means it is not metabolized in the liver or kidneys ." Continue reading >>

How Does Colesevelam (welchol) Work To Treat Type 2 Diabetes?

How Does Colesevelam (welchol) Work To Treat Type 2 Diabetes?

How does colesevelam (Welchol) work to treat type 2 diabetes? Colesevelam lowers bad (LDL) cholesterol and improves blood sugar control in adults with type 2 diabetes. Your doctor will call this type of drug a bile acid sequestrant. News release, FDA. . . WebMD Health News: "FDA Restricts Use of Diabetes Drug Avandia." News release, FDA. Reviewed by Michael Dansinger on February 26, 2017 News release, FDA. . . WebMD Health News: "FDA Restricts Use of Diabetes Drug Avandia." News release, FDA. How does linagliptin (Tradjenta) work to treat type 2 diabetes? THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911. This tool does not provide medical advice. See additional information. Continue reading >>

A1c & High Cholesterol Treatment | Welchol (colesevelam Hci)

A1c & High Cholesterol Treatment | Welchol (colesevelam Hci)

Welchol Mobile Communications Terms and Conditions There is no fee from Daiichi Sankyo, Inc. to receive messages. Message & data rates may applythis can be checked with your mobile service provider. Charges are billed and payable to your mobile service provider or deducted from your prepaid account. Consent is not a requirement for purchase. Data obtained from you in connection with this SMS service may include your cell phone number, your carrier's name and the date, time and content of your messages. We may use this information to contact you and to provide the services you request from us. Alerts sent via SMS may not be delivered if the mobile phone is not in range of a transmission site, or if sufficient network capacity is not available at a particular time. Even within a coverage area, factors beyond the control of the wireless carrier may interfere with message delivery, including the customer's equipment, terrain, proximity to buildings, foliage, and weather. The wireless carrier does not guarantee that alerts will be delivered and will not be held liable for delayed or undelivered messages. For information on data collection and use, please read our full corporate Privacy Policy . We will not be liable for any delays in the receipt of any SMS messages as delivery is subject to effective transmission from your network operator. The service is available on these US carriers only: Verizon Wireless, Sprint, Nextel , Boost, T-Mobile, AT&T, Alltel, ACS Wireless, Bluegrass Cellular, Carolina West Wireless, CellCom, Cellular One of East Central Illinois (ECIT), Cincinnati Bell, Cricket, C-Spire Wireless, Duet IP (AKA Max/Benton/Albandy), Element Mobile, Epic Touch, GCI Communications, Golden State, Hawkeye (Chat Mobility), Hawkeye (NW Missouri Cellular), Illinois Vall Continue reading >>

Welchol New Fda Drug Approval | Centerwatch

Welchol New Fda Drug Approval | Centerwatch

Welchol contains colesevelam hydrochloride, a non-absorbed,polymeric, lipid-lowering and glucose-lowering agent. It works bybinding bile acids, including the major bile acid in humans knownas glycocholic acid. However, the exact mechanism by which Welcholimproves glycemic control is unknown. Welchol is specifically indicated as an adjunct to diet andexercise to improve glycemic control in adults with type 2 diabetesmellitus. Welchol is supplied as a 625 mg tablet designed for oraladministration. The recommended initial dose of the drug is 6tablets once daily or 3 tablets twice daily. Welchol should betaken with a meal and liquid. The FDA approval of Welchol for this indication was based on theresults of three clinical trials. These double-blind,placebo-controlled add-on therapy trials enrolled a total of 1,018subjects with baseline A1C 7.5-9.5%. The subjects received Welchol,in combination with metformin, sulfonylureas or insulin or placeboadministered either as 3 tablets twice daily with lunch and dinneror as 6 tablets with dinner alone. Add-on Combination Therapy withMetformin: Welchol 3.8 g/day or placebo was added to background anti-diabetictherapy in a 26-week trial of 316 subjects already receivingtreatment with metformin alone (N=159) or metformin in combinationwith other oral agents (N=157). The combination of Welchol plusmetformin resulted in statistically significant placebo-correctedreductions in A1C with a -0.6 treatment difference (p<0.001) andFPG with a -14 treatment difference (p=0.10). The mean percentchange in serum LDL-C levels with Welchol compared to placebo was-16% among statin users and statin non-users; the median percentchange in serum TG levels with Welchol compared to placebo was -2%among statin users and 10% among statin non-users. The mean c Continue reading >>

Results Of The Glucose-lowering Effect Of Welchol Study (glows): A Randomized, Double-blind, Placebo-controlled Pilot Study Evaluating The Effect Of Colesevelam Hydrochloride On Glycemic Control In Subjects With Type 2 Diabetes.

Results Of The Glucose-lowering Effect Of Welchol Study (glows): A Randomized, Double-blind, Placebo-controlled Pilot Study Evaluating The Effect Of Colesevelam Hydrochloride On Glycemic Control In Subjects With Type 2 Diabetes.

The Hunter Holmes McGuire VA Medical Center, Richmond, Virginia 23249, USA. [email protected] This study evaluated the glycosylated hemoglobin (HbA(1c)-lowering effect of colesevelam hydrochloride, a bile acid sequestrant, in subjects with type 2 diabetes that was inadequately controlled by existing antihyperglycemic therapy. After a 4-week placebo run-in period, subjects with type 2 diabetes and an HbA(1c) value of 7.0% to 10.0% were randomized to receive colesevelam 3.75 g/d or matching placebo for 12 weeks. Subjects' previous oral anti hyperglycemic medication (sulfonylurea and/or metformin) was continued throughout the study. Fasting blood samples were obtained at weeks -5, -1, 0, 1, 4, 8, and 12. The primary efficacy end point was the change in HbA(1c) from baseline to week 12. Secondary end points included changes in fructosamine levels, fasting plasma glucose levels, postprandial glucose level, and meal glucose response (ie, difference between preprandial and postprandial levels), and percent changes in lipid parameters from baseline to week 12. The 65 randomized subjects (31 colesevelam, 34 placebo) had a mean age of 56.2 years and a mean body mass index of 32.4 kg/m(2); 55.4% were male and 53.8% were white. The difference in least squares (LS) mean (SE) change in HbA(1c) between the colesevelam group and the placebo group was -0.5% (0.18) (P = 0.007). In subjects with a baseline HbAIc > or = 8.0%, the difference in LS mean change in HbA(1c) was -1.0% (0.27) (P = 0.002). Relative to placebo, colesevelam treatment was associated with reductions in levels of fructosamine (-29.0 [10.9] pmol/L; P = 0.011) and postprandial glucose (-31.5 [13.6] mg/dL; P = 0.026). The mean percent change in low-density lipoprotein cholesterol was -9.6% in the colesevelam group, co Continue reading >>

Colesevelam Lowers Glucose And Lipid Levels In Type 2 Diabetes: The Clinical Evidence

Colesevelam Lowers Glucose And Lipid Levels In Type 2 Diabetes: The Clinical Evidence

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence 3Universit Lille Nord de France, Lille, France 1Tulane University Health Sciences Center in New Orleans, New Orleans, LA, USA 2Metabolic Institute of America, Tarzana, CA, USA 3Universit Lille Nord de France, Lille, France 6Institut Pasteur de Lille, Lille, France Correspondence to: Vivian A. Fonseca, MD, Professor of Medicine and Pharmacology, Tullis Tulane Alumni Chair in Diabetes, Chief Section of Endocrinology, Tulane University Health Sciences Center in New Orleans, 1430 Tulane Avenue SL 53, New Orleans, LA 70112, USA. E-mail: [email protected] Received 2009 Aug 12; Revised 2009 Oct 15; Accepted 2009 Nov 6. Copyright 2010 Blackwell Publishing Ltd Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. This article has been cited by other articles in PMC. Simultaneous control of blood glucose and other risk factors such as hypertension and dyslipidaemia is essential for reducing the risk of complications associated with type 2 diabetes mellitus (T2DM). As relatively few patients with T2DM have their risk factors managed to within the limits recommended by the American Diabetes Association, American College of Endocrinology or National Cholesterol Education Program Adult Treatment Panel III guidelines, treatment that can simultaneously control more than one risk factor is of therapeutic benefit. Clinical studies have shown that bile acid sequestrants have glucose-lowering effects in addition to their low-density lipoprotein cholesterol-lowering effects in patients with T2DM. The bile acid sequestrant colesevelam hydrochloride is approved as an adjunct to antidiabetes therapy for improving gl Continue reading >>

Welchol | Diabetic Mediterranean Diet

Welchol | Diabetic Mediterranean Diet

Colesevelam is used primarily to reduce elevated levels of LDL cholesterol. Its sold in the U.S. as WelChol. Remember that drug names vary by country and manufacturer. This is a brief review; consult your physician or pharmacist for details. Colesevelam is FDA-approved for treatment of type 2 diabetes in conjunction with insulin or diabetic pills. Three tablets twice daily with meals, or six tablets once daily with a meal. . . . serum triglycerides over 500 mg/dl, or have gastroparesis, other gastrointestinal motility disorders, risk factors for bowel obstruction, or recent major gastrointestinal procedures. Colesevelam (Welchol) Treatment for Type 2Diabetes David Mendosas May 20, 2009, blog post at HealthCentral.com brought to my attention a little-used diabetes drug, colesevelam HCl. Thebrand name is Welchol, and it has been around in the U.S. since 2000 for treatment of high cholesterol. Colesevelam is in a class called bile acid sequestrants. Taken in pill form, it is minimally absorbed from the gastrointestinal tract, which generally minimizes the chance for serious side effects. It can, however, interfere with absorption of many other drugs, thereby impairing the effectiveness of those drugs. The U.S. Food and Drug Administration has approved the drug for 1) treating high cholestrol, and 2) treatment of type 2 diabetes in combination with insulin or oral antidiabetes medications. So, its not a diabetic medication to be used by itself. The most common side effects are constipation and dyspepsia. WebMD has a patient-friendly article on colesevelam . I see very few patients using Welchol for treatment of diabetes, and Im not entirely sure why. It may be related to the interference with absorption of other drugs. Many people with diabetes are on multiple oral medicat Continue reading >>

About Type 2 Diabetes And High Cholesterol

About Type 2 Diabetes And High Cholesterol

WELCHOL is not for those with blood triglyceride levels of > 500 mg/dL Type 2 diabetes is the more common form of diabetes1 95% of people with diabetes have type 2 diabetes2,3 More than 90% of people with type 2 diabetes are overweight or obese3 Type 2 diabetes is often associated with obesity, family history, and physical inactivity.3 Common symptoms of diabetes may include urinating often, feeling very thirsty, feeling very hungry (even though you are eating), extreme fatigue, blurry vision, cuts/bruises that are slow to heal, and tingling, pain, or numbness in the hands and/or feet (type 2). However, some people with type 2 diabetes may not experience any symptoms.4 Type 2 diabetes in adults is a chronic condition that should be taken seriously Type 2 diabetes can be associated with many serious health complications including5: Neuropathy (tingling, pain, numbness, or weakness in the feet and/or hands) Kidney disease Eye complications Skin complications High blood pressure Stroke Welchol has not been shown to prevent heart disease, heart attacks, stroke, or any of the above risks. Please see "What is Welchol® (colesevelam HCl)" and "Important Safety Information about Welchol" below. The American Diabetes Association (ADA) explains that type 2 diabetes is a problem with the body that causes blood sugar levels to be high, either because the body doesn't make enough of the insulin hormone, or the body does not use insulin properly. When your body does not use insulin properly, this is called insulin resistance. At first, the pancreas makes extra insulin to make up for it. But, over time your pancreas isn’t able to keep up and can’t make enough insulin to keep your blood sugar levels normal. Type 2 diabetes is treated with lifestyle changes (healthy eating and exerc Continue reading >>

More in diabetes